BioAge Labs (BIOA) Other financing activities (2024 - 2026)

BioAge Labs (BIOA) has 3 years of Other financing activities data on file, last reported at $91000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $91000.0; the trailing twelve-month figure through Mar 2026 stood at $427000.0 (down 99.8% YoY), and the FY2025 full-year result was $336000.0, down 99.84% from the prior year.
• Other financing activities retreated to $91000.0 in Q1 2026, from $336000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $183.7 million in Q3 2024 to a low of $3000.0 in Q1 2024.
• A 3-year average of $35.4 million and a median of $379000.0 in 2024 frame the typical range for Other financing activities.
• Peak annual rise in Other financing activities reached 98.78% in 2025, while the deepest fall reached 98.78% in 2025.
• Tracing BIOA's Other financing activities over 3 years: stood at $27.6 million in 2024, then slumped by 98.78% to $336000.0 in 2025, then plunged by 72.92% to $91000.0 in 2026.
• Business Quant data shows BIOA's Other financing activities at $91000.0 in Q1 2026, $336000.0 in Q4 2025, and $27.6 million in Q4 2024.